Research
Please note that this research may have been paid for by the investment company. Any opinions and ratings are not endorsed by the AIC.
FundCalibre
09 September 2025
Terrible sentiment vs. compelling valuations: The healthcare opportunity.
Related articles
Fantasy fund manager: it’s a photo finish for the top spot
Fantasy fund manager: race goes down to the wire in competition’s final month
AIC fund manager poll: emerging markets tipped for the top in 2026
Related videos
Healthcare: From out of favour to underestimated
What makes this healthcare innovation cycle different?
Healthcare’s vital signs are improving
Polar Capital: AI, innovation and the outlook for healthcare
Related industry news
Trust Spot: Biotech Growth soars 21%; 3i Group regroups after May slump; Seraphim Space steps back from high
Biotechnology trusts BIOG and IBT replaced technology trusts as last month’s big risers with profit taking hitting Seraphim Space (SSIT) in June, but ...
Trust round up: GRID, HICL, BlackRock Frontiers, and Polar Capital Healthcare
We summarise the news from four investment companies, from infrastructure to frontier markets.
How healthy is your portfolio?
Over six months have passed since Cherry Reynard wrote about the biotech and healthcare sector for us in this article – The biotech bust: a case study...
Worldwide Healthcare back on the mend as good performance and presence of Saba stoke half-year return
Worldwide Healthcare (WWH) has posted its best first half performance in two decades as the £1.5bn investment trust managed by Orbimed in New York loo...
Investment company news brought to you by Citywire Financial Publishers Limited,
QuotedData by Marten & Co, Sharesify, and the armchair trader.
Data provided by Morningstar.
Company documents provided by FE fundinfo.